1. Mohammad Afzal Mohammad Afzal U.A.E. says:

    The Cost of Treatment is EXHORBITANT for poor and needy persons. I am shocked at the price of Interferon and Ribavirin, it is equivelant to one months salary of a poor person in growing economic regions. The insurance companies exclude themselves by mentioning pre-existing condition and refuse to take charge. The medicine companies have no heart...buying companies and research for Billions and have no heart for poor...

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post